CTC Bio received approval for Phase 1 clinical trial of 'CDFF0511' for the development of film-type Baraclude
On July 29, according to the Ministry of Food and Drug Safety, CTC Bio received approval for Phase 1 clinical trial of 'CDFF0511'. This clinical trial is for the development of film-type Baraclude from tablet form Baraclude.
The patent of Baraclude whose annual revenues are more than 100 billion...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
